HF
COEPW

HRT Financial’s Coeptis Therapeutics Warrants COEPW Stock Holding History

HRT Financial’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100,115
Closed -$2K – 2523
2024
Q2 		$2K Hold
100,115
– – ﹤0.01% 2077
2024
Q1 		$2K Hold
100,115
– – ﹤0.01% 2146
2023
Q4 		$3K Sell
100,115
-2,048
-2% -$80 ﹤0.01% 2151
2023
Q3 		$3K Buy
102,163
+2,739
+3% +$112 ﹤0.01% 2217
2023
Q2 		$6K Sell
99,424
-691
-0.7% -$82 ﹤0.01% 2214
2023
Q1 		$14K Hold
100,115
– – ﹤0.01% 2218
2022
Q4 		$10K Sell
100,115
-100
-0.1% -$7 ﹤0.01% 2222
2022
Q3 		$3K Buy
100,215
+100
+0.1% +$5 ﹤0.01% 2629
2022
Q2 		$3K Buy
+100,115
New +$7.52K ﹤0.01% 2772

Other funds holding COEPW

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

HRT Financial's COEPW Position: Q3 2024 in Review

HRT Financial sold out of Coeptis Therapeutics Warrants (COEPW) in Q3 2024, closing a stake of 100,115 shares — an estimated $2K sold.

HRT Financial first reported a position in COEPW in Q2 2022 and held it in 9 quarters. The position peaked at $14K in Q1 2023. 17 funds tracked by Wall St. Rank hold COEPW as of Q3 2024.

  • HRT Financial reported no remaining Coeptis Therapeutics Warrants position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 100,115 Coeptis Therapeutics Warrants shares in Q3 2024, an estimated $2K.
  • HRT Financial first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and held it in 9 quarters.
  • HRT Financial's Coeptis Therapeutics Warrants position peaked at $14K in Q1 2023.
  • 17 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.